BSEM

Biostem Technologies Inc

BSEM
Closed
$4.00
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The firm's products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AMERICAN AMNION. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. The company also owns BioTissue's surgical and wound care business, including the Neox and Clarix product lines.
Country

US

CEO

Mr. Jason Matuszewski

IPO date

2001

Employees

0

ISIN

US0906842002

Key stats

Open

$4.13

Volume

0.00

Market cap

$72.99M

Prev. close

$0.00

Impl / hst vl

-

Open interest

$0.00

$4.00

Day’s Range

$4.55

$0.00

52W Range

$0.00

Valuation

33
Valuation score
Overvalued
P/E
-
P/S
-
P/B
2.29
Current ratio
1.14
Debt / Equity
0.09
ROE
-47.03%
Gross margin
-
Income growth
-21.68%
FCF growth
-134.60

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.14
The top 3 analysts forecasts that 12-month price may increase by 78.50%, with a low of $7.07 and a high of $7.35
$7.07
Low
$7.14
Avg
$7.35
High
Current price

Earnings

Q1 ‘26 revenue
$6.14M
Q1 ‘26 net income
-$8.82M
Revenue
Net income
Previous EPS
-$0.52
Estimate EPS
-$0.51
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply